Globus Medical prices IPO at $12, low end of the revised range


Shutterstock photo

Globus Medical, which sells spine implants to hospitals for use in surgical procedures, raised $100 million by offering 8.3 million shares at $12.00, the low end of the revised range of $12.00 to $13.00. The company had previously filed to sell 11.8 million shares at a price range of $16.00 to $18.00. Globus Medical plans to list on the NYSE under the symbol GMED. BofA Merrill Lynch, Goldman Sachs and Piper Jaffray acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by